Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Harbour BioMed

Biotech & Life Sciences · Cambridge, United States · Founded 2016 · IPO 2020 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.02B
Market cap · Apr/2026
Revenue
$158M
Latest reported FY

Investors

19 investors on Harbour BioMed's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage
Legend Capital
Advantech Capital
Series B+ 17 investors entered at this stage
SK Group
Sovereign Wealth Funds
GIC
Zheshang Venture Capital
Country Garden
Vertex Holdings
Cambridge University Endowment Fund (CUEF)
OrbiMed
ShenZhen GTJA Investment Group
Zhejiang University Future Capital
Efung Capital
Hudson Bay Capital Management
JT New Century
Greater Bay Area Fund
China Life Private Equity Investment
Sage Partners
Octagon Capital Partners

Global footprint

Where Harbour BioMed has talent and traffic

Web traffic by country
6.3K monthly visits
across markets
🇺🇸 United States65.1%
🇮🇳 India15.9%
🇨🇦 Canada12.7%
🇯🇵 Japan4.8%
🇭🇰 Hong Kong1.6%
Top 5 markets shown

See Harbour BioMed on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo